Clarius Group LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$359K Sell
4,593
-176
-4% -$13.8K 0.02% 312
2025
Q1
$346K Sell
4,769
-78
-2% -$5.65K 0.02% 311
2024
Q4
$359K Buy
4,847
+404
+9% +$29.9K 0.02% 272
2024
Q3
$295K Sell
4,443
-108
-2% -$7.17K 0.02% 321
2024
Q2
$420K Sell
4,551
-111
-2% -$10.3K 0.03% 242
2024
Q1
$446K Sell
4,662
-657
-12% -$62.8K 0.03% 246
2023
Q4
$406K Sell
5,319
-1,248
-19% -$95.2K 0.03% 280
2023
Q3
$455K Sell
6,567
-2,003
-23% -$139K 0.04% 239
2023
Q2
$808K Buy
8,570
+389
+5% +$36.7K 0.06% 170
2023
Q1
$677K Buy
8,181
+198
+2% +$16.4K 0.06% 189
2022
Q4
$596K Sell
7,983
-66
-0.8% -$4.93K 0.05% 212
2022
Q3
$665K Sell
8,049
-59
-0.7% -$4.88K 0.07% 171
2022
Q2
$771K Buy
8,108
+1,134
+16% +$108K 0.08% 153
2022
Q1
$903K Hold
6,974
0.07% 151
2021
Q4
$903K Buy
6,974
+59
+0.9% +$7.64K 0.07% 151
2021
Q3
$783K Buy
6,915
+258
+4% +$29.2K 0.07% 152
2021
Q2
$689K Buy
6,657
+91
+1% +$9.42K 0.06% 162
2021
Q1
$549K Buy
6,566
+348
+6% +$29.1K 0.05% 174
2020
Q4
$567K Buy
6,218
+1,228
+25% +$112K 0.06% 157
2020
Q3
$398K Buy
4,990
+322
+7% +$25.7K 0.05% 173
2020
Q2
$323K Buy
4,668
+255
+6% +$17.6K 0.05% 206
2020
Q1
$277K Sell
4,413
-204
-4% -$12.8K 0.05% 189
2019
Q4
$364K Sell
4,617
-204
-4% -$16.1K 0.06% 169
2019
Q3
$353K Buy
4,821
+780
+19% +$57.1K 0.06% 162
2019
Q2
$249K Buy
4,041
+588
+17% +$36.2K 0.05% 202
2019
Q1
$220K Buy
+3,453
New +$220K 0.05% 186